Redmile Group, LLC, 10% Owner at ARRAY BIOPHARMA INC (ARRY), bought 300,000 shares at $3.19 ($957K) on 2016-01-20, disclosed to the SEC on 2016-01-22.
Open-market purchase of $957k ARRY by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Negative factors outweigh the positive ones.
| Filing → |
| FATE | BUY | 2023-12-28 | $332K | — | Filing → |
| IGMS | BUY | 2023-07-03 | $1.5M | — | Filing → |
| IGMS | SELL | 2023-07-03 | $1.5M | — | Filing → |